Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission
about
High Frequency of Genetic Recombination Is a Common Feature of Primate Lentivirus ReplicationAntimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells.Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNRHepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNRDC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by plateletsTrans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmissionDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virusDC-SIGN and L-SIGN Can Act as Attachment Receptors for Alphaviruses and Distinguish between Mosquito Cell- and Mammalian Cell-Derived VirusesThe advantages of PD1 activating chimeric receptor (PD1-ACR) engineered lymphocytes for PDL1(+) cancer therapyMechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: preference in virus entry is important but is not the sole factorHIV-1 transmission by dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) is regulated by determinants in the carbohydrate recognition domain that are absent in liver/lymph node-SIGN (L-SIGN)Identification of cellular proteins interacting with the retroviral restriction factor SAMHD1Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover eventsPatterns of Human Immunodeficiency Virus type 1 recombination ex vivo provide evidence for coadaptation of distant sites, resulting in purifying selection for intersubtype recombinants during replication.Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.HIV-1 Nef enhances dendritic cell-mediated viral transmission to CD4+ T cells and promotes T-cell activation.Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.Dendritic-cell interactions with HIV: infection and viral dissemination.Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.Effects of mutations in the human immunodeficiency virus type 1 Gag gene on RNA packaging and recombinationInterferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169.Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells.Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways.Retagging identifies dendritic cell-specific intercellular adhesion molecule-3 (ICAM3)-grabbing non-integrin (DC-SIGN) protein as a novel receptor for a major allergen from house dust miteCD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1Non-POU Domain-Containing Octamer-Binding Protein Negatively Regulates HIV-1 Infection in CD4(+) T Cells.Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cellsA novel high throughput quantum dot-based fluorescence assay for quantitation of virus binding and attachmentMinimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation.Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection.Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.Phosphorylation of mouse SAMHD1 regulates its restriction of human immunodeficiency virus type 1 infection, but not murine leukemia virus infection.Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue.Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cellsSAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferonsPostnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variantsFunctional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusion-mediated viral entry.Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma.
P2860
Q22242228-3DF3C490-D964-49FE-86C2-660DE4C26403Q24533368-C2B2980C-74D1-4ED4-B5F2-F3380F7E64EFQ24541155-53C33EB9-B455-4979-94E7-E0BCCA490EF5Q24551041-BBFC3A87-63CA-45EB-8DE1-C980043CAD07Q24673797-B5154DFE-67F1-4601-986F-DE9DC79250D9Q24801408-93B26250-BBB7-4EDB-ABCF-7C4ECFD72D32Q27010312-DCE3C0FF-7C9B-49D7-8265-DFF094C211D3Q27473455-86B47500-8C69-4156-AD8B-FB35B984E1D8Q27486897-2BE528E9-6FDF-4F2F-8989-CC44796D7667Q28646882-88397972-68F9-4956-93B8-64F0A587FF8FQ30448451-D9B8294C-B925-45E3-A7F5-52A96F19F471Q33582027-08E4A5E4-7A8C-486A-8887-2C26E0087102Q33602815-700F89AB-6B22-40BB-B97F-7945109ECF6EQ33716831-00C7910C-6878-4AC5-93B5-29118CA73094Q33964088-D2E83F20-B31F-400A-BEDA-9990FB15A5AFQ34016211-B2894E28-3241-4B5D-8660-9EC97946CAA4Q34222643-01FB3CA6-4D64-457E-854B-C48A587AF7C8Q34263217-4ECFCB56-2D71-404C-8064-C675732F902AQ34572043-2F0ACE7F-24F6-489D-BCC7-6A9A597F9AC6Q34574823-BFA788AD-80DD-443D-8930-CDC62F5343C7Q34647902-54718757-27CE-4421-AFE3-1F7BBD5229BCQ34671896-1AFFC2FD-617D-458D-A966-69049F4A934EQ35496414-7AC764F8-2AD0-4977-B826-8B8B750E8A5FQ35735892-2A05CB02-02D1-42F3-BFB3-BA45AA2F615AQ35774076-07CB70FC-7002-4BE7-B189-2E49CD915CCCQ35784676-30081AAE-E9BB-4138-9E5C-0779474B4CDCQ35942573-91329D70-24EB-4CCC-B951-34D6A740566CQ35947996-8ADD2524-0E6F-4BDD-A2A6-6EB8B58ADAB0Q35989311-ED45CE21-8A8C-4959-821D-7BB0081B790CQ36019742-D9FA9290-E84C-4B1D-8302-C2D0007C8070Q36099361-05B96C10-1CFA-44AC-9660-F8AF02F8870FQ36315149-8F98FF5E-D5C3-4659-BC7E-E05E7534259CQ36372744-C13C2A1B-C884-49E8-9EF7-C8A6F3299426Q36399466-E9B61DEE-8810-462B-A235-5F4CB6CEF1DCQ36448906-11700ED9-67C5-44BD-850C-C4FEF7189A0DQ36480173-B03F863F-2892-46B3-B723-5F36F929BBFFQ36588632-CD8E99D8-4502-46DA-96BC-9437125E1321Q36761995-553E02BE-C9F4-4754-8212-2E366BEC3139Q36844056-0FE81E29-CEA8-48B0-A104-1B88DB0F31ACQ36858767-D54FDB33-5A47-4803-8701-4D5D8CEB6EA5
P2860
Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@ast
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@en
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@nl
type
label
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@ast
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@en
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@nl
prefLabel
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@ast
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@en
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@nl
P2093
P2860
P921
P3181
P1433
P1476
Functional evaluation of DC-SI ...... ency virus type 1 transmission
@en
P2093
Derya Unutmaz
Rosemay Vazeux
Thomas D Martin
Vineet N KewalRamani
P2860
P304
P3181
P356
10.1128/JVI.76.12.5905-5914.2002
P407
P50
P577
2002-06-01T00:00:00Z